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ABSTRACT
Objectives: To compare the clinical,
socioeconomic and demographic characteristics of
individuals diagnosed with Neisseria gonorrhoeae
(NG) in the community using a concomitant nucleic
acid amplification test (NAAT, AptimaCombo2) as
part of the (community-based) UK Chlamydia
Screening Programme (CSP), with those diagnosed
in hospital-based genitourinary medicine (GUM)
services.
Design: A retrospective case note review of all 643
patients treated for NG at a GUM in north west England
(January 2007–April 2009).
Participants: All 643 treated for NG (including CSP
cases, since all cases were referred to GUM for
treatment). Limited data were available for 13 CSP
cases who failed to attend GUM.
Primary outcome measure: Whether the case
was detected in the community or GUM services.
Predictors were demographics (age, gender,
postcode for deprivation analysis), sexual history (eg,
number of partners) and clinical factors (eg, culture
positivity).
Results: 131 cases were diagnosed by CSP (13 of
whom did not attend GUM). A further four cases were
contacts of these. The GUM caseload was thus inflated
by 23% (from 521 to 643). Community cases were
overwhelmingly female (85% vs 27% in GUM,
p<0.001) and younger (87% females were <25 years
vs 70% GUM females, p=0.001). Logistic regression
analysis restricted to the target age of the CSP
(<25 years) revealed that CSP cases, compared with
GUM cases, were more likely to reside in deprived
areas (adjusted OR=5.6, 95% CI 1.4 to 21.8 and 5.3,
CI 1.7 to 16.6 for the most and second most deprived
group respectively, compared with the averagely
deprived group, p=0.037) and be asymptomatic
(adjusted OR=1.9, CI 1.1 to 3.4, p=0.02).
Conclusions: Community screening for NG led to a
79% increase in the number of infections detected in
women aged <25 years. Screening is targeted at young
people, and tends to disproportionately attract young
women, a group under-represented at GUM. Screening
also contributed further to case detection in deprived
areas.
INTRODUCTION
Nucleic acid ampliﬁcation tests (NAATs)
have greater sensitivity than culture and are
now widely used to diagnose sexually trans-
mitted infections (STIs), including Neisseria
gonorrhoeae (NG) using non-invasive and
easily transportable samples. However, in low-
prevalence populations where an NG NAAT
might not display a positive predictive value
exceeding 90%, positive samples are now
recommended to be subjected to conﬁrma-
tory testing.1
The UK national Chlamydia Screening
Programme (CSP) is an opportunistic screen-
ing programme which uses NAATs for
Chlamydia trachomatis (CT). The programme is
targeted at all young people aged under
25 years (although tends to be predominantly
taken up by women2), and based in commu-
nity settings such as pharmacies, community
Strengths and limitations of this study
▪ Little attention has been paid to the possibility
that screening programmes improve diagnosis in
populations that would not traditionally attend
genitourinary medicine services. This study fills
a gap in knowledge about the socioeconomic
status of those identified in the different settings.
▪ Neisseria gonorrhoeae (NG) cases were over-
represented in particular relatively deprived areas
of the study area, as shown by geodemographic
profiling (the Mosaic tool).
▪ Community screening for NG contributed extra
female cases, asymptomatic male cases and
cases from relatively more deprived areas, which
may have otherwise remained undetected.
▪ As a retrospective review of cases, there were no
controls, limiting the conclusions from this study.
▪ The deprivation results and Mosaic groups should
be interpreted with caution, since such area-level
measures of deprivation may not represent the
characteristics of individuals.
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contraception clinics, primary care, schools and colleges.
Concomitant NAAT screening for CT and NG (Aptima
Combo 2 assay, Gen-Probe Inc, San Diego, California,
USA) using either self-taken or clinician samples was intro-
duced into the study area CSP in 2004 at the same cost as a
CT test alone. Cases of NG identiﬁed are subsequently
referred to the specialist genitourinary medicine (GUM)
service for parenteral treatment, specialist partner notiﬁca-
tion and antibiotic sensitivity testing. The overall detection
of NG has increased in areas where such an approach has
been implemented.3–5
Previous studies of NG epidemiology have been based
on GUM clinic populations6–8 and therefore less is
known about the characteristics of cases that are detected
outside GUM. Such analysis that does exist conﬁrms the
characteristics that would be expected based on the
target and the settings of the screening programme (ie,
young women).5 Little attention has been paid to the pos-
sibility that screening programmes improve diagnosis in
populations that would not traditionally attend GUM.
This study compares the demographic and clinical
proﬁle of NG cases detected by the CSP with that of a
GUM clinic population with a speciﬁc aim to ﬁll the gap
in knowledge about the socioeconomic status of those
identiﬁed in the different settings.
METHODS
A cross-sectional retrospective case note review was com-
pleted in all cases of complicated and uncomplicated NG
attending a GUM service between 1 January 2007 and 31
March 2009, identiﬁed from GUM clinic records (using
the Sexual Health and HIV Activity Property Type—
SHHAPT—surveillance report codes). The GUM is
located in a large city, adjacent to some of the most
deprived areas in England. The referral route was
recorded as follows: diagnosed in the open-access GUM
clinic; referred from the CSP; a contact of an NG case;
referred from general practice. Demographic data col-
lected included: postcode (to allow allocation of an area-
based deprivation measure and use of a postcode classiﬁ-
cation tool, Mosaic, that uses over 400 data indicators to
classify all UK citizens into 15 population types, ‘Mosaic
groups’), gender, age (either <25 years, the target age for
the CSP, or ≥25 years) and ethnicity. Clinical data were:
symptoms of NG; NG culture results; CT test result. Clinic
policy was for NG culture samples to be recommended as
a minimum of one sample per NG from up to four ana-
tomical sites in total: pharynx, rectum, cervix (women
only) and urethra. Culture result was recorded as ‘posi-
tive’ if one or more was positive, and ‘negative’ if all were
negative. CT testing was by in-house NAAT on urine
samples alone. Sexual history variables included sex
between men (although this was poorly completed and
thus omitted from the analysis) and number of partners
recorded in the previous 3 months, as per the national
guidelines at the time for taking a sexual history.9 All clin-
ical and behavioural data were collected by the GUM,
irrespective of the source of the diagnosis. GUM clinical
policy includes routine recommendation of NG culture
samples from the urethra and throat in all men with NG,
plus a sample from the rectum in men who had sex with
men (MSM). For females, NG culture samples are rou-
tinely recommended from the cervix, throat and rectum.
NG cases were deﬁned as patients who tested positive
with NAAT, and adhered to the standards set out by
Public Health England.1 These policies were consistent
irrespective of referral route. Patients not referred from
the CSP were also tested with the GUM service in-house
combined CT/GC PCR NAAT. Basic data (age, gender
and postcode) were also available from the CSP for all
individuals referred to GUM with a positive NG screening
test who then failed to attend for treatment.
Cases were assigned a study number and pseudoanony-
mised. Postcodes were linked to the lower super output
area of residence (a statistical unit representing ∼1500
population) and then to area-level deprivation categories
(English quintiles of deprivation, Index of Multiple
Deprivation 200710). Only 3% of cases resided in the
least deprived two-ﬁfths, so these cases were merged with
the averagely deprived category. First, the distribution of
NG is displayed by Mosaic group, and compared with the
distribution of city’s households using χ2 goodness of ﬁt
tests. Then, the demographic and clinical characteristics
of CSP cases were compared with GUM cases using uni-
variate χ2 analysis, ﬁrst for all cases and then for
<25-year-olds (the target age range of the CSP). Cases
with missing data were excluded from the analysis (ethni-
city missing: 7; missing partner information: 14; symp-
toms and culture missing: 17. Cases with missing data
were predominantly the 13 who were diagnosed by CSP
but did not attend the GUM). Logistic regression (SPSS
V.20), using the source of the cases (CSP or GUM) as the
outcome, was used to assess independent relationships.
RESULTS
In total, 656 cases were identiﬁed, 131 (20%) of whom
were diagnosed as a result of community screening (114
primary cases who attended GUM for treatment, four
contacts of primary cases and 13 who were diagnosed in
the community but did not present to GUM for treat-
ment). The community-diagnosed population, and their
contacts, together inﬂated the GUM caseload by 23%
(from 521 to 643, not including the 13 who did not
present to GUM). Allocation to deprivation group and
Mosaic group was possible for 576 (88%) of records.
Since the proportion of records with unknown depriv-
ation category was relatively high, and because the prob-
ability of missing data in this ﬁeld is not random (the
probability of missing postcode data is related to depriv-
ation and other risk indicators11), the missing values
were coded as ‘deprivation unknown’ and retained in
the analysis.
Table 1 shows the distribution of NG cases by Mosaic
groups. The relatively afﬂuent groups (B, C and D) are at
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Table 1 Distribution of cases of Neisseria gonorrhoeae by Mosaic residential category, compared with the distribution of the general population of the city
Mosaic category
All cases (n=578) Aged under 25 years (n=340)
N (%)
Expected
N (%)*
Standardised
residual† N (%)
Expected
N*
Standardised
residual‡
B Residents of small and mid-sized towns with strong local roots 5 (0.86) 11.2 (1.94) 7.69 4 (1.2) 6.6 (1.94) 1.02
C Wealthy people living in the most sought after neighbourhoods 3 (0.52) 9.7 (1.67) 14.96 3 (0.9) 5.7 (1.67) 1.26
D Successful professionals living in suburban or semirural homes 7 (1.2) 14.4 (2.49) 7.82 5 (1.5) 8.5 (2.49) 1.42
E Middle income families living in moderate suburban semis 55 (9.45) 61.8 (10.69) 0.84 35 (10.3) 36.3 (10.69) 0.05
F Couples with young children in comfortable modern housing 6 (1.03) 11.9 (2.05) 5.8 2 (0.6) 7 (2.05) 3.54
G Young, well-educated city dwellers 66 (11.34) 77.7 (13.45) 2.07 33 (9.7) 45.7 (13.45) 3.55
H Couples and young singles in small modern starter homes 5 (0.86) 14.5 (2.5) 18.05 3 (0.9) 8.5 (2.5) 3.56
I Lower income workers in urban terraces in often diverse areas 66 (11.34) 60.2 (10.42) 0.51 39 (11.5) 35.4 (10.42) 0.36
J Owner occupiers in older-style housing in ex-industrial areas 23 (3.95) 26.8 (4.63) 0.63 14 (4.1) 15.7 (4.63) 0.19
K Residents with sufficient incomes in right-to-buy social houses 48 (8.25) 43.3 (7.49) 0.46 23 (6.8) 25.5 (7.49) 0.24
M Elderly people reliant on state support 23 (3.95) 29.8 (5.16) 2.01 9 (2.6) 17.5 (5.16) 4.16
N Young people renting flats in high density social housing 76 (13.06) 50.9 (8.8) 8.29 35 (10.3) 29.9 (8.8) 0.86
O Families in low-rise social housing with high levels of benefit need 188 (32.3) 155.5 (26.9) 5.62 128 (37.6) 91.5 (26.9) 14.59
U Unclassified 7 (1.2) 10.4 (1.8) 1.65 7 (2.1) 6.1 (1.8) 0.13
*Expected number of cases in each Mosaic category if cases were proportionally distributed to the general population distribution in the city where the clinic is located. Data taken from Upton
et al12 which cites the Experian Mosaic Public Sector Tool.
†χ2 Goodness of fit of observed distribution (cases of gonorrhoea) against expected (general population)=46.9; df=13, p<0.001.
‡χ2 Goodness of fit of observed distribution (cases of gonorrhoea in those aged under 25 years) against expected (general population)=34.9, df=13, p=0.001.
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the top of the table (group A, a rural category, does not
occur in the study city). The distribution of NG does not
follow the expected distribution based on the distribution
of all households in the study area (p<0.001 for all cases;
p<0.001 for cases in people aged under 25 years).
Inspection of the residuals reveals that cases of NG were
under-represented in the wealthy groups B, C, D and F,
and in the average group H. Cases were over-represented
in ‘N-Young people renting ﬂats in high density social
housing’ and ‘O-Families in low-rise social housing with
high levels of beneﬁt need’. Group O itself is over-
represented in the study area (27%) compared with
nationally (5%)12; in this study, 32% of all cases and 38%
of cases in those aged under 25 years of all NG cases
resided in ‘O’. Numbers of cases in each Mosaic group
were too low to compare CSP cases with GUM cases.
Including all cases, whether attending the GUM for
treatment or not (N=656), there were more males diag-
nosed with NG than females (404 vs 252). The CSP pre-
dominantly contributed female cases (111, 85% of cases
vs 27% female in GUM, χ2=148.4, p<0.001), leading to a
79% increase in the number of female cases that would
have been detected in the absence of the CSP (from
141 to 252). The community cases and their contacts
were labelled as ‘CSP’ to represent the additional cases
(n=131). Cases labelled as ‘GUM’ (n=525) represent
those diagnosed at GUM (ie, 465 self-referrals to the
open access clinic, 19 referrals from general practice
and 41 contacts). Similar numbers of females were iden-
tiﬁed by GUM and CSP (table 2). Not surprisingly, given
the target age of the screening programme (those
under 25 years), the CSP group was younger (87% were
aged under 25 years vs 70% GUM, p=0.001). CSP
females were more likely to reside in deprived areas
compared with GUM females (p=0.014). Overall, only
43% of females had symptoms of NG. Not all cases
found positive by NAAT were subsequently found to be
positive by culture (overall, 10% of NAAT positive cases
were not positive by culture, and this was higher for
females, 18%, than males, 5%). Cases found positive by
NAAT were treated as NG, as per national guidance.1 In
particular, females diagnosed NAAT positive for NG by
the CSP (by Aptima Combo2) were more likely to be
culture negative than were females identiﬁed NAAT
positive by the in-house GUM PCR (25% vs 14% GUM,
p=0.028). Of the 19 male CSP cases who subsequently
attended GUM, 8 had no symptoms (42%). In contrast,
only 12% of those identiﬁed through the GUM were
symptomless (p<0.001). CT positivity was not signiﬁ-
cantly associated with setting in NG-positive patients,
either for males (20.4% positive at GUM vs 31.6% at
CSP; p=0.243) or females (29.8% positive at GUM vs
41.4% positive at CSP, p=0.064).
The CSP targets younger persons aged under 25 years
and therefore the univariate χ2 comparisons were
repeated restricting to this younger age group in order to
compare the proﬁle of younger persons accessing the
GUM with those using opportunistic screening. Results
were similar to the all-age comparisons: there was no sig-
niﬁcant difference in the probability of being culture
negative between the two settings (χ2 =1.714, p=0.130);
there was no signiﬁcant association between CT positivity
and setting (χ2 =0.2, p=0.650); and men diagnosed in the
community remained signiﬁcantly less likely to have
symptoms than younger men diagnosed in the GUM (χ2
=4.996, p=0.037). Young females diagnosed in the com-
munity remained more likely to reside in deprived areas
compared with young female GUM patients (χ2=16.3,
p=0.001). Findings from the univariate analysis were con-
ﬁrmed using multivariate analysis to ﬁnd independently
signiﬁcant predictors of young people being detected by
CSP rather than GUM (table 2). Analysis was restricted to
this younger age group and conﬁrmed that CSP cases
were much more likely to be female (adjusted OR=9.9,
95% CI 4.9 to 19.8, p<0.001). After statistically controlling
for the effect of gender, CSP cases had a two times higher
odds (95% CI 1.1 to 3.6, p=0.021) of being symptomless
and a ﬁve times higher odds of residing in the fourth or
ﬁfth most deprived quintiles compared with GUM cases
(fourth: adjusted OR=5.4, 95% CI 1.4 to 20.9; ﬁfth:
adjusted OR=5.3, 95% CI 1.7 to 16.6; p=0.038).
DISCUSSION
As a retrospective review of cases, there were no controls,
limiting the conclusions from this study. Data recorded
were variable in quality, and in particular there were
only restricted data on those who were diagnosed by
CSP but did not attend GUM. p Values of the univariate
tests should be interpreted with caution since many tests
were carried out, thereby increasing the risk of type I
errors. The deprivation results and Mosaic groups
should be interpreted with caution, since such area-level
measures of deprivation may not represent the
characteristics of individuals. An example of where area-
level descriptors may be less helpful is the excess of
cases of NG in those aged under 25 years (ie, a young
group) in areas typiﬁed by containing more older resi-
dents (the Mosaic group ‘M-older people reliant on
state support’: table 1).
Despite these limitations, we have shown that use of
NAATs can greatly increase the number of NG cases
detected outside of clinic settings and have obtained epi-
demiological evidence of the demographic character-
istics associated with these additional cases. This study
conﬁrms the association of NG with poverty that has
been noted in the USA13 and the UK,7 and adds further
insight by mapping to the 15 Mosaic groups. More than
one-third of cases came from a single Mosaic group,
which represented deprived communities and these
were disproportionately represented compared with the
study area as a whole. Community screening for NG con-
tributed an additional 23% to the GUM caseload.
Testing targeted was those aged under 25 years, and pre-
dominantly attracts women. Although not surprising,
this has resulted in a doubling of NG infections detected
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Table 2 Demographic and clinical characteristics of cases of Neisseria gonorrhoeae diagnosed in the GUM service compared with those identified as a result of the CSP,
by gender
Males Females
Multivariate predictors of those
aged <25 years being diagnosed
by CSP*
GUM CSP χ p Value GUM CSP χ p Value Adjusted OR (95% CI) p Value
Gender
Male – – – – – – – – 1 <0.001
Female – – – – – – – – 9.5 (4.7 to 19.2)
Age† (N) 384 20 141 111
<25 (%) 50.3 85.0 9.2 0.002 69.5 86.5 10.1 <0.001 –‡ –
≥25 (%) 49.7 15.0 30.5 13.5
Ethnicity (N) 379 20 141 109
Not white (%) 9.8 10.0 <0.1 1.000 14.9 10.1 1.3 0.34 0.9 (0.4 to 2.1) 0.866
White (%) 90.2 90.0 85.1 89.9 1
IMD quintile§ (N) 384 20 141 111
Average deprivation (%) 7.8 0 1.9 0.577 15.6 3.6 16.4 <0.001 1 0.037
Fourth most deprived (%) 12.8 10.0 7.8 10.8 5.6 (1.4 to 21.8)
Most deprived (%) 67.4 75.0 69.5 66.7 5.3 (1.7 to 16.6)
Unknown (%) 12.0 15.0 7.1 18.9 5.6 (1.3 to 23.8)
Partners¶ (N) 384 19 141 98
One (%) 21.6 31.6 1.9 0.384 63.8 54.1 3.6 0.165 1 0.244
Two (%) 56.5 57.9 31.2 42.9 1.4 (0.8 to 2.6)
Three or more (%) 21.9 10.5 5 3.1 1.0 (0.3 to 3.1)
Symptoms (N) 381 19 141 98
No (%) 11.8 42.1 14.5 <0.001 53.2 63.3 2.4 0.121 1.9 (1.1 to 3.4) 0.021
Yes (%) 88.2 57.9 46.8 36.7 1
Culture (N) 384 18 140 97
Negative (%) 4.9 0 0.9 0.334 13.6 24.7 4.8 0.028 1 0.370
Positive (%) 95.1 100 86.4 75.3 0.7 (0.3 to 1.5)
CT status (N) 382 19 141 99
Negative (%) 79.6 68.4 1.4 0.243 70.2 58.6 3.5 0.064 1 0.442
Positive (%) 20.4 31.6 29.8 41.4 1.3 (0.7 to 2.2)
CSP includes primary cases diagnosed in the community and four partners diagnosed as a result of contact tracing.
GUM includes primary cases, self-referrals, referrals from general practice and partners of primary GUM cases.
*Logistic regression analysis with source of case as the outcome (CSP=1; GUM=0), restricted to those aged under 25 years (n=404) who have complete data for partner number, symptoms and
culture history (n=385). Predictor variables: gender, ethnicity, IMD, number of partners, CT status, symptoms (yes or no) and culture (negative or positive). Adj OR are adjusted ORs of being
diagnosed by the CSP, with 95% CIs.
†χ2 Analysis was repeated restricting to <25-year-olds, and results were similar (see text).
‡Age was excluded from multivariate analysis because analysis was restricted to <25 years.
§Least deprived and second least deprived quintiles were merged with the average deprivation category.
¶Number of partners in previous 3 months.
CSP, Chlamydia Screening Programme; GUM, genitourinary medicine; IMD, index of multiple deprivation.
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in women in that age category, and these cases may have
remained undetected in the absence of community
screening.
Compared with the age-matched GUM women, the
women detected by the CSP were qualitatively different,
being yet more likely to reside in deprived areas, suggest-
ing that community screening had accessed a yet more
vulnerable population. CSP cases (especially males) were
less likely to have symptoms, and therefore presumably
less likely to present to clinical services. Although only
statistically signiﬁcant in the small number of males, we
found a higher proportion of the community samples
were culture negative. NG culture samples were obtained
at the GUM clinic according to a strict policy based on
gender and sexual history rather than route of referral
and thus differences in culture results are unlikely to be
the result of different testing practice. Our results
support the notion that NG-positive samples originating
from community sites might more often represent low
bacterial load or asymptomatic infection14 15 although
this conclusion is limited by the low sensitivity of bacter-
ial culture for gonorrhoea.
Since the data collection for this study was carried out,
public policy on CT screening has been updated. The new
Public Health Outcome Framework (PHOF) is used to
monitor targets to increase the number of diagnoses (in
the ﬁrst instance, with the expectation that the target will
be eventually to reduce prevalence).16 The major over-
arching aim of the PHOF is to reduce inequalities in
health.17 Although there are no speciﬁc NG targets, our
data show that opportunistic CT/NG screening may con-
tribute to reductions in health inequality by disproportion-
ately beneﬁtting lower SES groups. This is in direct
contrast to other opportunistic screening programmes,
which risk increasing such inequalities (eg, for breast and
cervical cancer18). The opportunity, within the CSP, to use
low-cost testing to detect low level, asymptomatic infections
in a wider population has the potential to be an important
inﬂuence on NG control and may contribute to the gov-
ernment’s target to reduce health inequalities.
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